These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7377145)

  • 1. Heparin anticoagulation during cardiopulmonary bypass in an antithrombin-III deficient patient. Implications relative to the etiology of heparin rebound.
    Soloway HB; Christiansen TW
    Am J Clin Pathol; 1980 May; 73(5):723-5. PubMed ID: 7377145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin sensitivity test for patients requiring cardiopulmonary bypass.
    DeBois WJ; Liu J; Elmer B; Ebrahimi H; Voevidko L; Lee LY; Krieger KH; Isom WW; Girardi LN
    J Extra Corpor Technol; 2006 Dec; 38(4):307-9. PubMed ID: 17312901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin resistance during cardiopulmonary bypass].
    Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
    Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of heparin resistance due to acquired antithrombin III deficiency.
    Leong CK; Ong BC
    Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass.
    Finley A; Greenberg C
    Anesth Analg; 2013 Jun; 116(6):1210-22. PubMed ID: 23408671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report.
    Brinks HJ; Weerwind PW; Verkroost MW; Nováková I; Brouwer MH
    Perfusion; 2000 Nov; 15(6):553-6. PubMed ID: 11131221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of real-world heparin resistance and anticoagulation management prior to cardiopulmonary bypass: report from a nationwide survey by the Japanese Association for Thoracic Surgery heparin resistance working group.
    Ito K; Sasaki K; Ono M; Suzuki T; Sakamoto K; Okamoto H; Katori N; Momose N; Araki Y; Tojo K; Ieko M; Komiyama Y; Saiki Y
    Gen Thorac Cardiovasc Surg; 2024 Jan; 72(1):8-14. PubMed ID: 37195584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
    Muedra V; Bonanad S; Gómez M; Villalonga V; Sánchez F; Llopis JE
    Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass.
    Davidson SJ; Woodhams B
    Int J Lab Hematol; 2011 Dec; 33(6):614-6. PubMed ID: 21569219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
    Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating heparin resistance with antithrombin or fresh frozen plasma.
    Spiess BD
    Ann Thorac Surg; 2008 Jun; 85(6):2153-60. PubMed ID: 18498854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
    Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
    Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Annuloaortic ectasia associated with antithrombin III deficiency; report of a case].
    Fujiwara Y; Yamada T; Katsuyama K; Utsumi T
    Kyobu Geka; 2013 Jul; 66(7):589-92. PubMed ID: 23917140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial Septal Defect with Hereditary Deficiency of Antithrombin III].
    Naruse H; Sakamoto Y; Kinouchi K; Inoue T; Matsumura Y; Yoshitake M; Bando K; Hashimoto K
    Kyobu Geka; 2016 Jul; 69(7):508-10. PubMed ID: 27365061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.